Tradestie Institutional Equity Comparison Engine

AKRO vs FOLD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-04-24 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

FOLD Overall Edge

FOLD Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Amicus Therapeutics, Inc (FOLD) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AKRO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus FOLD at 17.7x Forward P/E and 8.6% operating margin (+23.7% YoY). In options structure, AKRO sits in UNCLASSIFIED (30th %ile IV; Dealer Gamma Walls on Pro) against FOLD sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner FOLD
AKRO N/M vs FOLD 17.7x Fwd P/E
Growth & Margin Winner FOLD
Op Margin 0.0% vs 8.6% ยท YoY +0.0% vs +23.7%
Momentum & Technical Winner FOLD
1Y +76.8% vs +104.1% ยท 52W Pos 90% vs 100%
Options & Structure Winner FOLD
UNCLASSIFIED (30th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
AKRO NASDAQ
Akero Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$54.65
+0.32% 1D
Market Cap $4.5B
1M Return +1.37%
1Y Return +76.75%
Forward P/E N/M
Unified AI Score
60.0 / 100 BUY
Tech 55.0 Fund 52.0 Flow 50.0 Mom 50.0
FOLD NASDAQ
Amicus Therapeutics, Inc
Pharmaceutical Preparations
$14.49
+0.21% 1D
Market Cap $4.5B
1M Return +0.42%
1Y Return +104.08%
Forward P/E 17.7x
Unified AI Score
59.4 / 100 HOLD
Tech 40.0 Fund 52.0 Flow 71.0 Mom 46.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AKRO +76.75% FOLD +104.08% Spread: +0.76 pp (FOLD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AKRO TTM Op. Margin: 0.0% FOLD TTM Op. Margin: 8.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AKRO vs FOLD. Trailing 12-month operating profitability (AKRO 0.0% vs FOLD 8.6%) and valuation multiples (AKRO N/M vs FOLD 17.7x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AKRO (2) vs FOLD (8)
Institutional Metric AKRO FOLD Criterion Row Winner
Market Capitalization Scale $4.5B $4.5B Larger Scale FOLD
Trailing P/E Ratio Valuation N/M 30.5x Lower Multiple FOLD
Forward P/E Ratio Valuation N/M 17.7x Lower Multiple FOLD
Revenue Growth (YoY) Growth +0.0% +23.7% Higher Growth FOLD
Operating Margin (TTM) Profitability 0.0% 8.6% Higher Margin FOLD
Net Profit Margin Profitability 0.0% -4.3% Higher Margin AKRO
Return on Equity (ROE) Capital Efficiency -34.5% -11.6% Higher ROE FOLD
52-Week Range Position Momentum 90% ($21โ€“$58) 100% ($6โ€“$14) Stronger Trend FOLD
Beta / 30D Volatility Risk Regime 0.90ฮฒ ยท 2% Vol 0.27ฮฒ ยท 2% Vol Lower Realized Risk FOLD
Unified Institutional Score Composite Signal 60.0 / 100 (BUY) 59.4 / 100 (HOLD) Higher Composite AKRO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AKRO vs FOLD Buy Guide
AKRO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 30th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live AKRO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FOLD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live FOLD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AKRO nor FOLD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.